KALA PHARMACEUTICALS
Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient-friendly format. The company's research efforts have demonstrated... successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept while establishing R&D collaborations with select partners to improve products in their pipelines.
KALA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2009-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.kalarx.com
Total Employee:
101+
Status:
Active
Contact:
1(781) 996-5252
Email Addresses:
[email protected]
Total Funding:
506.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Amazon IPv6
Similar Organizations
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Kiora Pharmaceuticals
Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Zietchick Research Institute, LLC
The Zietchick Research Institute, LLC specializes in developing new treatments for eye diseases that primarily affect mothers and infants.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Kala Pharmaceuticals
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Equity - Kala Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series C - Kala Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series C - Kala Pharmaceuticals
CAM Capital
CAM Capital investment in Series C - Kala Pharmaceuticals
OrbiMed
OrbiMed investment in Series C - Kala Pharmaceuticals
Longitude Capital
Longitude Capital investment in Series C - Kala Pharmaceuticals
Lux Capital
Lux Capital investment in Series C - Kala Pharmaceuticals
Wellington Management
Wellington Management investment in Series C - Kala Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series C - Kala Pharmaceuticals
Official Site Inspections
http://www.kalarx.com Semrush global rank: 36.76 K Semrush visits lastest month: 3.58 M
- Host name: aa0d276b28f6a5dd6.awsglobalaccelerator.com
- IP address: 75.2.68.162
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Kala Pharmaceuticals"
Kala Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Kala Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone …See details»
Kala Pharmaceuticals - Get In Touch - kalarx.com
[email protected] (opens new window) INVESTOR RELATIONS CONTACT. Stern Investor Relations Hannah Deresiewicz. hannah. [email protected] (opens new window) +1 …See details»
Kala Pharmaceuticals Management Team | Org Chart
Kalarx.com; View Similar People. Related Companies Column Health. 55 $5.6m ARLINGTON PEDIATRIC ASSOCIATES, P.C. 11 $3m TARIS Bio. 25 $12.7m Ellenhorn. 83 $10m …See details»
Kala Pharmaceuticals Strengthens Commercial Organization in …
May 9, 2018 We believe that the collective talent, leadership and seasoned industry experience of our new team members will greatly advance Kala’s evolution into a commercial …See details»
Kala Pharmaceuticals - Overview, News & Similar companies
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference ARLINGTON, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a …See details»
Kala Pharmaceuticals - VentureRadar
"Kala Pharmaceuticals, Inc. is advancing innovative treatments for ocular diseases addressing significant needs in both front and back of the eye based on the company's proprietary Mucus …See details»
Kala Pharmaceuticals - Craft
Oct 29, 2024 Kala Pharmaceuticals has 4 employees at their 1 location and $3.89 m in annual revenue in FY 2022. See insights on Kala Pharmaceuticals including office locations, …See details»
RELEASE DETAILS - investors.kalarx.com
WATERTOWN, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, …See details»
Kala Pharmaceuticals Announces Name Change to KALA BIO
Aug 2, 2023 In connection with the name change, KALA BIO’s corporate website address remains unchanged at www.kalarx.com. The company’s common stock will continue to be …See details»
Working At Kala Pharmaceuticals: Company Overview and Culture
Mar 14, 2024 www.kalarx.com. Organization Type. Public. CEO. Mark T. Iwicki. Social Media. Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. …See details»
Kala Pharmaceuticals Announces Name Change to KALA BIO
ARLINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (Nasdaq:KALA), a clinical-stage biopharmaceutical company dedicated to the research, …See details»
Kala Pharmaceuticals - Golden
Kala Pharmaceuticals is a biotechnology company headquartered in Waltham, Massachusetts and was founded in 200 by Justin Hanes and Robert Langer.. The name Kala, from Kala …See details»
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2021 ...
ARLINGTON, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, …See details»
KALA BIO - LinkedIn
Nov 11, 2021 KALA BIO | 22,322 followers on LinkedIn. Welcome to the KALA Journey | Weaving along Hawaii's Na Pali Coast is the famous, breathtaking Kalalau trail. This trail is not …See details»
RELEASE DETAILS - investors.kalarx.com
Nov 12, 2024 For more information on KALA, please visit www.kalarx.com. Forward Looking Statements: This press release contains forward-looking statements within the meaning of the …See details»
KALA BIO Inc. - Cruelty Free Investing
Company Website: https://kalarx.com Contact: [email protected] ©2024 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization | LEGALSee details»
ACCESS TO INVESTIGATIONAL MEDICINES PRIOR TO …
Please visit our website at www.kalarx.com or visit www.clinicaltrials.gov. Author: Eric Trachtenberg Created Date: 7/21/2023 5:48:03 PM ...See details»
Kala Pharmaceuticals Announces the Launch of INVELTYS™ and …
Jan 7, 2019 – Experienced specialty ophthalmology sales organization fully hired and sales representatives and payor account team actively calling on customers – WALTHAM, Mass.- …See details»
Kala Pharmaceuticals - Our Technology - kalarx.com
The term “secretome” describes the biofactors secreted by cells into the extracellular space. In the case of our lead product KPI-012, these biofactors include classes of proteins such as matrix …See details»